Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Cooper Ronald Harold Wilfred, Chief Executive Officer. Director active across 3 companies, notably Albireo Pharma, INC.. In total, 13 filings have been logged. Breakdown: 1 buy · 6 sells. Total volume traded: €261k. History available since 17 September 2021. The latest transaction was disclosed on 27 September 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Cooper Ronald Harold Wilfred
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11,973 shares@ US$19.1950.4% of flowCommon StockSEC:0001209191-21-056860:0
13 of 13 declarations
About Cooper Ronald Harold Wilfred
Cooper Ronald Harold Wilfred is Président et Directeur Général. He has 13 filings in total, and in the sampled recent filings the period runs from 2021-09-20 to 2026-02-09, with buy amounts of EUR 50997 and sell amounts of EUR 209972.